Myocardial and Pericardial Toxicity Associated With Immune Checkpoint Inhibitors in Cancer Patients

We recount a single-center experience with cardiac immunity-related adverse effects in patients treated with immune checkpoint inhibitors. Of 2,830 patients, 9 patients (0.3%) developed cardiac immunity-related adverse effects (4 cases of cardiomyopathies, 2 of myocarditis, 2 of acute pericarditis,...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:JACC Case Rep
Egile Nagusiak: Chahine, Johnny, Collier, Patrick, Maroo, Anjli, Tang, W.H. Wilson, Klein, Allan L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2020
Gaiak:
Mini-Focus Issue: Myocardial and Pericardial Inflammation
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8298653/
https://ncbi.nlm.nih.gov/pubmed/34317203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaccas.2019.11.080
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak